chartexchange

Cellebrite: 3 Key Takeaways for Long-Term Investors

The Motley Fool | Nov 14, 2026 9:43 PM EST

On its third-quarter 2026 earnings call, held on Nov. 12, 2026, Cellebrite (NASDAQ:CLBT) reported annual recurring revenue, the annualized value of active subscription contracts, grew 20% year over year to $528.5 million. The digital forensics provider is shifting from single-device data extraction tools into an artificial intelligence investigative software platform. Three things management said stand out. Management launched Genesis, an artificial intelligence tool that searches evidence like video and audio calls to surface investigative leads in minutes. Customers reprioritized spending to buy it during the quarter, generating $2 million in annual recurring revenue in its first full quarter. Foreign entity status created sales delays in the U.S. and Europe. Management plans to complete a redomiciliation to the United States in the first half of 2027 to eliminate hurdles to purchasing and gain eligibility for major U.S. stock indices. Continue reading

Read original article